Structures by: Parise-Filho R.
Total: 6
31
C23H30F3N3O,2(C2F3O2)
RSC Medicinal Chemistry (2020)
a=8.23301(6)Å b=13.02347(14)Å c=13.57687(16)Å
α=98.1817(9)° β=92.5946(8)° γ=103.5389(8)°
19
C20H32N3O2,C2F3O2,1.65(H2O)
RSC Medicinal Chemistry (2020)
a=17.41370(10)Å b=8.14510(10)Å c=33.6364(2)Å
α=90° β=90.4130(10)° γ=90°
Cis-22a
C22H29N3
RSC Medicinal Chemistry (2020)
a=7.2232(3)Å b=8.9059(4)Å c=15.2815(6)Å
α=96.464(3)° β=95.779(3)° γ=99.987(4)°
9
C24H34N2O2,2(C2F3O2)
RSC Medicinal Chemistry (2020)
a=12.18020(10)Å b=16.45030(10)Å c=14.08290(10)Å
α=90° β=93.2560(10)° γ=90°
40
C23H29F3N3O2,C2F3O2,C4H10O
RSC Medicinal Chemistry (2020)
a=15.6425(3)Å b=12.7231(2)Å c=16.3931(3)Å
α=90° β=106.097(2)° γ=90°
Crystal_OP18
C14H14N2O3S
ACS Sustainable Chemistry & Engineering (2016) 4, 4 1899
a=11.5414(3)Å b=12.2880(6)Å c=10.9161(5)Å
α=90° β=115.252(2)° γ=90°